Listed

Mesa Laboratories Inc: Form 10-K for the period ended Mar 31, 2019

Filed with the SEC on Jun 3, 2019 and accepted by EDGAR at Jun 3, 2019, 11:57 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2019-03-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2019-01-01 to 2019-03-31$26.4mus-gaap:Revenues
Revenue12 months2018-04-01 to 2019-03-31$103.1mus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Cost of revenue12 months2018-04-01 to 2019-03-31$42.2mus-gaap:CostOfRevenue
Gross profit3 months2019-01-01 to 2019-03-31$15.6mus-gaap:GrossProfit
Gross profit12 months2018-04-01 to 2019-03-31$60.9mus-gaap:GrossProfit
Research and development12 months2018-04-01 to 2019-03-31$3.5mus-gaap:ResearchAndDevelopmentExpense
Operating income12 months2018-04-01 to 2019-03-31$9.8mus-gaap:OperatingIncomeLoss
Income tax12 months2018-04-01 to 2019-03-31$1.1mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2019-01-01 to 2019-03-31$1.4mus-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
Net income12 months2018-04-01 to 2019-03-31$7.5mus-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
Diluted EPS3 months2019-01-01 to 2019-03-31$0.34us-gaap:EarningsPerShareDiluted
Diluted EPS12 months2018-04-01 to 2019-03-31$1.86us-gaap:EarningsPerShareDiluted
Basic EPS3 months2019-01-01 to 2019-03-31$0.36us-gaap:EarningsPerShareBasic
Basic EPS12 months2018-04-01 to 2019-03-31$1.95us-gaap:EarningsPerShareBasic
Diluted shares (weighted)12 months2018-04-01 to 2019-03-314,033,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow12 months2018-04-01 to 2019-03-31$30.6mus-gaap:NetCashProvidedByUsedInOperatingActivities
Dividends paid12 months2018-04-01 to 2019-03-31$2.5mus-gaap:PaymentsOfDividends
Cash and equivalentsAt period end2019-03-31$10.2mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2019-03-31$33.6mus-gaap:AssetsCurrent
Total assetsAt period end2019-03-31$156.8mus-gaap:Assets
Current liabilitiesAt period end2019-03-31$23.7mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2019-03-31$45.5mus-gaap:Liabilities
Long-term debtAt period end2019-03-31$20.6mus-gaap:LongTermDebtNoncurrent
Current portion of debtAt period end2019-03-31$2.1mus-gaap:LongTermDebtCurrent
Shareholders' equityAt period end2019-03-31$111.3mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001437749-19-011234. Last ingested by Listed: Nov 13, 2026, 07:45 ET. Listed shows no prices and gives no investment advice.